日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial

节拍式口服帕唑帕尼联合拓扑替康治疗复发性胶质母细胞瘤(伴或不伴贝伐单抗治疗):一项 II 期临床试验的结果

Ozer, Byram H; Cohen, Adam L; Colman, Howard; Penas-Prado, Marta; de Groot, John; Loghin, Monica E; Pan, Edward; Raizer, Jeffrey J; Kumthekar, Priya; Fink, Karen L; Walbert, Tobias; Merrell, Ryan T; Groves, Morris D; Ahluwalia, Manmeet S; Wu, Jing; Burton, Eric C; Vera, Elizabeth; Mendoza, Tito; Grajkowska, Ewa; Wall, Kathleen; Reyes, Jennifer; Yuan, Ying; Armstrong, Terri S; Gilbert, Mark R

Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design

评估复发性脑膜瘤挽救性全身治疗的疗效:RANO 小组系统评价和荟萃分析,以指导临床试验设计

Kotecha, Rupesh; Akdemir, Eyub Y; Kutuk, Tugce; Ilgın, Can; Ahluwalia, Manmeet S; Bi, Wenya L; Blakeley, Jaishri; Dixit, Karan S; Dunn, Ian F; Galanis, Evanthia; Galldiks, Norbert; Huang, Raymond Y; Johnson, Derek R; Kaley, Thomas J; Kamson, David O; Kurz, Sylvia C; McDermott, Michael W; Odia, Yazmin; Preusser, Matthias; Raizer, Jeffrey; Reardon, David A; Rogers, C Leland; Ruda, Roberta; Schiff, David; Vogelbaum, Michael A; Weller, Michael; Wen, Patrick Y; Mehta, Minesh P

Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors

达唑替纳联合帕博利珠单抗治疗接受低分割放射治疗的特定晚期实体瘤患者的 1b 期研究

Cooper, Benjamin T; Iams, Wade T; Page, David B; Yuan, Yuan; Gerber, Naamit K; Luke, Jason J; Gibbs, John P; Gregory, Richard C; Wong, Kwok-Kin; Deng, Jiehui; Perera, Samanthi A; Ding, Kai; Roberts, Emily R; Berger, Allison; Christensen, Camilla L; Tong, Erica Xin; Maldonado López, Angel E; Appleman, Vicky A; Leonard, E Jane; Parent, Alexander; Huang, Yu-Chung; Bay, Camden; Li, Cong; Lineberry, Neil; Raizer, Jeffrey; Olson, Daniel J; Chmura, Steven J

CNSC-37. SENSITIVITY TO DAILY GLUCOCORTICOIDS DEPENDS ON SEX IN GLIOBLASTOMA

CNSC-37. 胶质母细胞瘤对每日糖皮质激素的敏感性取决于性别

Mejia Perez, Lady Katherine; Confer, Bradley; Veniero, Joseph; Raymond, Daniel; Bhatt, Amit; Jaeckle, Kurt; Vogelbaum, Michael; Ballman, Karla; Giannini, Caterina; Aldape, Kenneth; Cerhan, Jane; Wefel, Jeffrey; Nordstrom, Donald; Jenkins, Robert; Klein, Martin; Raizer, Jeffrey; van den Bent, Martin; Wick, Wolfgang; Flynn, Patrick; Dhermain, Frederick; Cairncross, Gregory; Brown, Paul; Norton, Emily; Mewborne, Quinlan; Suarez-Meade, Paola; Quinones-Hinojosa, Alfredo; Clark, Victoria; Gonzalez-Aponte, Maria F; Aripova, Nigina; Salvatore, Sofia V; Simon, Tatiana; Rubin, Joshua B; Herzog, Erik D

DISP-10. RACIAL AND SOCIOECONOMIC DIFFERENCES IN CLINICAL AND ACCESS TO CARE OUTCOMES IN NEUROSURGICAL-ONCOLOGY PATIENTS

DISP-10. 神经外科肿瘤患者临床结果和就医机会的种族和社会经济差异

Tsien, Christina I; Pugh, Stephanie L; Dicker, Adam P; Raizer, Jeffrey J; Matuszak, Martha M; Lallana, Enrico C; Huang, Jiayi; Algan, Ozer; Deb, Nimisha; Portelance, Lorraine; Villano, John L; Hamm, John T; Oh, Kevin S; Ali, Arif N; Kim, Michelle M; Lindhorst, Scott M; Mehta, Minesh P; Prabhu, Ashna; Perryman, Travis; Harper, Stuart; Carson, Amani; Dudley, Lindsey; Delgadillo, Alondra; Gor, Aidan; Patel, Kunal

A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy

贝伐珠单抗治疗复发/进展性实体瘤脑转移患者(接受全脑放射治疗后病情进展)的II期临床试验

Dixit, Karan; Singer, Lauren; Grimm, Sean Aaron; Lukas, Rimas V; Schwartz, Margaret A; Rademaker, Alfred; Zhang, Hui; Kocherginsky, Masha; Chernet, Sofia; Sharp, Laura; Nelson, Valerie; Raizer, Jeffrey J; Kumthekar, Priya

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

一项针对新诊断胶质母细胞瘤患者的口服pexidartinib联合放射疗法和替莫唑胺的1b/2期研究

Mendez, Joe S; Cohen, Adam L; Eckenstein, Midori; Jensen, Randy L; Burt, Lindsay M; Salzman, Karen L; Chamberlain, Marc; Hsu, Henry H; Hutchinson, Marguerite; Iwamoto, Fabio; Ligon, Keith L; Mrugala, Maciej M; Pelayo, Michael; Plotkin, Scott R; Puduvalli, Vinay K; Raizer, Jeffrey; Reardon, David A; Sterba, Michael; Walbert, Tobias; West, Brian L; Wong, Eric T; Zhang, Chao; Colman, Howard

A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics

一项针对伴有软脑膜转移的人表皮生长因子受体2阳性(HER2阳性)癌症的鞘内曲妥珠单抗I/II期研究:安全性、有效性和脑脊液药代动力学

Kumthekar, Priya U; Avram, Michael J; Lassman, Andrew B; Lin, Nancy U; Lee, Eudocia; Grimm, Sean A; Schwartz, Margaret; Bell Burdett, Kirsten L; Lukas, Rimas V; Dixit, Karan; Perron, Isabella; Zhang, Hui; Gradishar, William J; Pentsova, Elena I; Jeyapalan, Suriya; Groves, Morris D; Melisko, Michelle; Raizer, Jeffrey J

ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

ILUSTRO:一项针对晚期或转移性 Claudin 18.2 阳性胃或胃食管交界处腺癌患者的 Zolbetuximab II 期多队列试验

Klempner, Samuel J; Lee, Keun-Wook; Shitara, Kohei; Metges, Jean-Phillippe; Lonardi, Sara; Ilson, David H; Fazio, Nicola; Kim, Tae Yong; Bai, Li-Yuan; Moran, Diarmuid; Yang, Jianning; Arozullah, Ahsan; Park, Jung Wook; Raizer, Jeffrey J; Bang, Yung-Jue; Shah, Manish A

Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma

佐贝妥昔单抗治疗CLDN18.2阳性胃癌或胃食管交界处腺癌日本患者的I期临床试验

Shitara, Kohei; Kawazoe, Akihito; Hirakawa, Akihiro; Nakanishi, Yuka; Furuki, Satomi; Fukuda, Musashi; Ueno, Yoko; Raizer, Jeffrey; Arozullah, Ahsan